Laparoscopic Devices Market Size, Share & Trends Analysis Report By Product (Laparoscopes, Energy Systems, Trocars), By Application (Bariatric Surgery, Other Surgery), By End-user (Hospital, Clinic), By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The global laparoscopic devices market size was estimated at USD 7.29 billion in 2023 and is expected to surpass around USD 14.82 billion by 2033 and poised to grow at a compound annual growth rate (CAGR) of 7.35% during the forecast period 2024 to 2033.

Key Takeaways:

• The energy systems segment dominated the market for laparoscopic devices and captured the largest revenue share of around 21.1% in 2023.
• The hospital segment dominated the market for laparoscopic devices and accounted for the largest revenue share of 63.0% in 2023.
• The other surgeries segment dominated the market for laparoscopic devices and accounted for a revenue share of around 22.5% in 2023.
• North America dominated the laparoscopic devices market and accounted for the highest revenue share of 36.0% in 2023.

Laparoscopic Devices Market Report Scope

The growth of the market is attributed due to the increasing incidence of obesity across all age groups, the rapidly growing geriatric population in the Asia Pacific region, especially in countries such as Japan, India, and China, and quick technological improvements. The COVID-19 pandemic has created a significant challenge for the global healthcare industry. Restricted access to medical services has led to inadequate care for patients suffering from other diseases. Laparoscopy has been adversely impacted by the pandemic. During this period, surgeries are often even canceled or postponed to the lower transmission of the virus.

Key players are planning to extend their businesses regionally and create new warehouses in other locations, as well as run their operations through numerous channels in the worst-affected areas. Companies are using a variety of tactics to deal with supply chain disruptions, including rerouting logistics, sourcing from extra partners, and air freight delivery. Local manufacturers have also benefited from the pandemic. These factors are expected to create lucrative opportunities for market growth.

In recent times, laparoscopic surgery is preferred more than conventional ones owing to its numerous benefits, such as shorter hospital stay, decreased blood loss, and lower patient morbidity of laparoscopy, as well as offering quick recovery time, rapid and successful outcomes, low risk of infection, small or no incision and less pain. Since the demand for laparoscopic surgery is significantly increasing, the demand for laparoscopic devices is likely to also grow during the forecast period. The factors driving the growth of the market are the increasing number of patients suffering from health issues such as uterine fibroids, and endometriosis, the rising number of hysterectomy and myomectomy procedures, and growing awareness about the improving healthcare infrastructure in emerging economies.

In addition, supportive government policies and laws of the countries are boosting the growth of the market for laparoscopic devices. Moreover, some countries have supportive reimbursement policies, which are anticipated to increase the sales of laparoscopic power morcellators in those regions. Laparoscopic devices applications are expanding due to a noteworthy increase in worldwide elderly demographics and the expansion of energy systems, which is increasing their availability and affordability. Laparoscopic devices, which incorporate energy systems, are expected to find lucrative uses in various applications in bariatric surgeries, such as gastric bypass, sleeve gastrectomy, adjustable gastric band, and biliopancreatic diversion with duodenal switch.

Furthermore, a rising inclination for minimally invasive laparoscopic equipment is moving this market ahead. Minimally invasive surgical methods are becoming more popular because of the reduced trauma. For instance, in December 2020, Olympus announced the addition of 3D and infrared capabilities to their VISERA ELITE II surgical imaging platform for minimally invasive surgery. The addition of such an imaging platform could help hospitals and operation centers to improve efficiency and cut expenses. The product is useful in a variety of applications, such as gynecology, general surgery, orthopedic surgery, endourology, and ENT. Furthermore, in some countries, health insurance companies pay for minimally invasive laparoscopic surgeries. For example, according to the Medicare Benefits Schedule, Medicare now covers up to 75% of laparoscopic procedures (MBS). Patients' preferences for minimally invasive surgeries have risen because of these considerations.

The U.S. dominated the market for laparoscopic devices and accounted for the largest revenue share. This can be attributed to increasing reliance on laparoscopic surgeries over open surgeries and increasing awareness about the benefits of minimally invasive. In addition, competition among prominent players, related to product innovation, will also impact the market. For instance, in September 2023, the THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open surgery was recently introduced by Olympus Corporation. With an added thermal shield, the device promotes better safety during procedures and is available commercially in Japan.

The companies are also working on a range of strategic sourcing and diversity programs. For instance, in August 2020, B. Braun Medical and Kerma Medical Products announced a collaboration to advance the development and delivery of healthcare products and services, with an emphasis on veterans, minorities, and other underserved communities. Both companies are expected to work on a range of areas, including co-marketing opportunities, product development, sustainable manufacturing, strategic sourcing, and diversity programs, which is expected to boost market growth soon.

Product Insights

The energy systems segment dominated the market for laparoscopic devices and captured the largest revenue share of around 21.1% in 2023. Energy systems allow rapid sequential tissue and vessel sealing, transection, and coagulation during laparoscopic surgery. These systems have wide application in bariatric surgeries, such as gastric bypass, sleeve gastrectomy, adjustable gastric band, and biliopancreatic diversion with duodenal switch. According to the IFSO Global Registry Report 2019, 833,687 bariatric surgeries were performed in 61 countries globally in 2019. Thus, the abovementioned factors are expected to fuel market growth during the forecast period.

The insufflation device segment is expected to witness the highest CAGR of 7.9% over the forecast period. Insufflation devices allow for easy and safe persufflation with humidified carbon dioxide of the abdominal cavity. The rising frequency and incidence of diseases such as colorectal cancer are the factors likely to fuel market expansion. For instance, colorectal cancer was the third most frequent cancer in women and men in 2020, according to the World Cancer Research Fund International, with around 1.90 million new cases reported. Colorectal cancer is most treated with laparoscopic surgery. As a result, the rising prevalence of colorectal cancer is predicted to boost the market growth.

End-user Insights

The hospital segment dominated the market for laparoscopic devices and accounted for the largest revenue share of 63.0% in 2023. The growth of this segment can mainly be attributed to an increase in the number of patients suffering from various chronic diseases and the consequent rise in surgical procedures. In comparison to other healthcare settings, hospitals see a significantly higher inflow of patients for bariatric surgeries or other laparoscopic procedures, owing to the ease of handling any emergencies that may arise during surgical procedures and the availability of a wide range of treatment options in such facilities. For instance, according to the American Society for Metabolic and Bariatric Surgery, in 2019 alone, 256,000 people in the U.S. underwent weight-loss surgery. Thus, the aforementioned factors are expected to drive the hospitals' segment.

Moreover, hospitals are the primary health system in most countries; therefore, the number of laparoscopic surgeries done at hospitals is relatively high than in other healthcare settings such as ambulatory surgery centers or clinics. Thus, the demand for laparoscopic devices in hospitals is comparatively high than in other end-use segments. The ambulatory surgical centers' segment is expected to witness the highest CAGR of 7.1% during the forecast period. The ambulatory surgical centers' segment is expected to grow at a significant pace over the forecast period. The lucrative expansion of the market for the laparoscopic device is due to an increase in the adoption of minimally invasive surgeries, a high desire for outpatient surgeries, and the cost-effectiveness of ambulatory surgical center-based laparoscopic procedures.

Lower postsurgical complications in minimally invasive laparoscopic surgery, on the other hand, are predicted to boost demand for ambulatory surgery facilities. In comparison to hospitals, they provide patients with various benefits, including same-day release and faster procedure times. Because laparoscopic operations are less invasive, most intra-abdominal surgeries can now be performed at ambulatory surgical centers. Aesthetic procedures at ambulatory surgery facilities are not only less time-consuming but also less expensive than inpatient procedures, lowering patient costs. As a result of the factors discussed above, the ambulatory surgery centers segment is expected to rise rapidly over the forecast period.

Application Insights

The other surgeries segment dominated the market for laparoscopic devices and accounted for a revenue share of around 22.5% in 2023. Cholecystectomy laparoscopy, appendectomy laparoscopy, thoracic laparoscopy, colon laparoscopy, and prostrate laparoscopy are among the most common procedures. Colon laparoscopy, for instance, is predicted to rise steadily because of ongoing innovation aimed at improving its success rate. Thus, this segment is expected to witness a moderate growth rate over the forecast period. The bariatric surgeries segment is expected to witness the highest CAGR of 8.40% during the forecast period, owing to the increasing incidence of obesity in adults due to excessive intake of calories and changing lifestyle habits is the major driver for segment growth.

For instance, according to CDC, around 13.0% of the population (aged 18 and above) are obese and 41.0 million children under the age of 5 years suffer from obesity. Furthermore, the American Heart Association has estimated the total medical cost for bariatric surgery to reach up to USD 957.0 billion from USD 861.0 billion by 2030. Moreover, government support and increased awareness about unhealthy food/drinks available in the market and their impact on BMI are factors further expected to increase the demand for bariatric surgeries during the forecast period. Laparoscopic devices are among the essential requirements for bariatric surgeries and increasing demand for such surgeries is anticipated to fuel segment growth.

Regional Insights

North America dominated the laparoscopic devices market and accounted for the highest revenue share of 36.0% in 2023. Increasing dependence on laparoscopic surgeries compared to open surgeries is a major factor driving the market. In addition, competition among prominent players, related to product innovation, will also impact the market for the laparoscopic device. Furthermore, surgeons are now recommending laparoscopy over traditional surgeries, as it allows for rapid healing and positive outcome. In addition, increasing healthcare expenditure in the U.S. may also favor the entry of both new and old players. For instance, as per the Centers for Medicaid and Medicare Services, U.S. health care spending increased by 9.7% and reached USD 4.1 trillion in 2020, accounting for approximately 19.7% of the GDP.

In Asia Pacific region, the market for laparoscopic devices is expected to witness a CAGR of 7.8% during the forecast period owing to an increase in the number of advanced, well-equipped hospitals and a large number of surgical procedures are boosting the market growth in the Asia Pacific over the forecast period. Singapore and South Korea are some of the emerging economies in the Asia Pacific region. Advancing technology, increasing investment, improving reimbursement scenarios, and growing medical tourism are likely to drive the market in the region. Other driving factors for the country are affordable devices, an increase in mergers and acquisitions, and government initiatives to improve healthcare services. The government has made significant investments to provide basic health insurance to all citizens.

Some of the prominent players in the Laparoscopic devices market include:

• Karl Storz SE & CO. Kg
• Medtronic
• Johnson and Johnson
• Olympus Corporation
• CONMED Corporation
• B. Braun Melsungen AG
• The Cooper Companies Inc.
• Richard Wolf GmbH
• Microline Surgical
• BD
• Welfare Medical Ltd
• DEAM
• Intuitive Surgical
• Shenzen Mindray Bio Medical Electronics Co., Ltd

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global laparoscopic devices market.

Product

• Laparoscopes
• Energy Systems
• Trocars
• Closure Devices
• Suction/ Irrigation Device
• Insufflation Device
• Robot Assisted Systems
• Hand Access Instruments

Application

• Bariatric Surgery
• Urological Surgery
• Gynecological Surgery
• General Surgery
• Colorectal Surgery
• Other Surgeries

End-user

• Hospital
• Clinic
• Ambulatory

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)